As of April 16, 2025, Phathom Pharmaceuticals (PHAT) has a market cap of $0.33 billion USD. According to our data, Phathom Pharmaceuticals is ranked No.6405 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.33 B |
-40.17%
|
Dec 31, 2024 | $0.56 B |
-11.06%
|
Dec 29, 2023 | $0.62 B |
-18.63%
|
Dec 30, 2022 | $0.77 B |
-42.96%
|
Dec 31, 2021 | $1.34 B |
-40.79%
|
Dec 31, 2020 | $2.27 B |
6.68%
|
Dec 31, 2019 | $2.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Ironwood Pharmaceuticals
IRWD
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
Market Cap | = | PHAT Stock Price | * | PHAT Shares Outstanding |
= | $4.77 | * | 69.64 M | |
= | $0.33 B |